Research Scientist: Organic Chemist, Medicinal Chemistry (Contract)
Biohaven Pharmaceuticals Inc
Application
Details
Posted: 24-Jul-24
Location: Pittsburgh, Pennsylvania
Type: Temp to Full Time
Salary: $65k - $80k
Categories:
Biotechnology & Laboratory
Salary Details:
Compensation will be commensurate with the candidate’s experience and training
Preferred Education:
4 Year Degree
At Biohaven, we are committed to improving the lives of patients by advancing first-in-class and best-in-class therapies for a variety of neurological and non-neurological indications.
A research scientist in the Medicinal Chemistry Research team will use organic synthetic methodology to prepare drug candidates as part of our drug discovery research organization.
This is a full time contract position located in Pittsburgh, PA reporting to a senior scientist. Salary and title will be commensurate with level of experience.
Responsibilities:
In collaboration with a Senior Scientist, implement the synthesis of small-molecule organic compounds as drug candidates that target unmet medical needs
Maintain an accurate and up-to-date electronic notebook
Participate in group, project team and departmental research meetings
Work in a highly dynamic and team-oriented manner with Medicinal Chemistry and Biology team members to execute discovery programs with ambitious goals
The successful applicant will possess the following personal qualifications, with the ability to articulate examples of key achievements and characteristics:
Excellent listening, speaking, and writing skills
Effective problem-solving skills and behaviors
Collaborative skills, including respect for alternate views
A commitment to goals, a sense of urgency in fulfilling ambitious objectives, with high personal performance standards and self-accountability
Minimum of bachelor’s degree in chemistry
Relevant laboratory/work experience preferred
Experience working in an organic synthesis laboratory preferred
At Biohaven, we are committed to discovering, developing, and commercializing life-changing new therapies for people with debilitating diseases. Leveraging our proprietary platforms, we are advancing paradigm-shifting treatment options to improve the lives of people with debilitating neurological and neuropsychiatric diseases, including rare disorders and a broad range of adjacent indications.